Title:
NON-INVASIVE DIAGNOSTIC IMAGING AGENT FOR HEART DISEASE
Document Type and Number:
WIPO Patent Application WO/2019/216223
Kind Code:
A1
Abstract:
The present invention provides compounds that accumulate at a high level in cardiac lesions and are suitable as a nuclear medicine tracer in PET imaging, enables in vivo detection of cardiac lesions by using said compounds, and provides a non-invasive diagnostic imaging agent for heart disease containing as an active ingredient a radiolabeled compound represented by formula (1) or a salt thereof. [In the formula, X1 represents a hydrogen atom or a halogen atom, X2 represents a fluorine atom or a nitrile group, and X3 represents a radioactive fluorine atom.]
Inventors:
MAYA YOSHIFUMI (JP)
Application Number:
PCT/JP2019/017441
Publication Date:
November 14, 2019
Filing Date:
April 24, 2019
Export Citation:
Assignee:
NIHON MEDIPHYSICS CO LTD (JP)
International Classes:
A61K51/04; A61K101/02
Domestic Patent References:
| WO2017213247A1 | 2017-12-14 | |||
| WO2015199205A1 | 2015-12-30 |
Other References:
ABE, T. ET AL.: "A Novel CYP11B2-Specific Imaging Agent for Detection of Unilateral Subtypes of", PRIMARY ALDOSTERONISM, J CLIN ENDOCRINOL METAB, vol. 101, no. 3, 2016, pages 1008 - 15, XP055456963, ISSN: 0021-972X, DOI: 10.1210/jc.2015-3431
Attorney, Agent or Firm:
IDE Masatake (JP)
Download PDF: